Why Biggest Healthcare ETF ‘XLV’ Has Been Sick
The healthcare sector is in the midst of a stunning first-to-worst act. Last year, the sector was the best-performing group…
XLV
Health Care Select Sector SPDR Fund
$85.97 +$0.05
(+0.06%)
As of 6:40:00 PM EDT | 4/22/19 | Market Closed
XLV Trading Data
Open
$85.78
Low Price
$85.51
High Price
$86.46
Previous Last Price
$85.92
Bid Size
$85.85 X 300
Ask Size
$86.36 X 200
XLV Portfolio Data
AUM
$17,443,308,800
Shares
203,065
PE Ratio
15.94
Price / Book Ratio
4
Expense Ratio
0.13
Net Asset Value
$85.90
Volume
Volume
18,717,699
Avg. Volume (YDT)
10,379,041
Dollar Volume
$17,272
Weekly Avg. Volume
22,235,840
Monthly Avg. Volume
11,729,870
Quarterly Avg. Volume
10,120,522
XLV Fund Description
The Health Care Select Sector SPDR Fund seeks to provide investment results that, before expenses, correspond generally to the price and yield performance of the Health Care Select Sector Index.
XLV Chart
XLV Summary
Fund Family
State Street Global Advisors
Tracks This Index
Health Care Select Sector SPDR Fund
Inception Date
1998-12-16
Asset Class
Equity
Asset Class Size
Biotech
XLV Classification
Region (General)
North America
Region (Specific)
US
Sector
Health Care
Equity Index
Leveraged Family
XLV Holdings
Top 10 Holdings
Johnson & Johnson (JNJ)
11.35%
Pfizer Inc. (PFE)
6.78%
UnitedHealth Group Incorporated (UNH)
6.59%
Merck & Co. Inc. (MRK)
5.86%
Abbott Laboratories (ABT)
4.02%
AbbVie Inc. (ABBV)
3.55%
Medtronic plc (MDT)
3.5%
Amgen Inc. (AMGN)
3.42%
Thermo Fisher Scientific Inc. (TMO)
3.24%
Eli Lilly and Company (LLY)
3.08%
Total XLV Holdings
Total Holdings: 65
Johnson & Johnson (JNJ)
11.35%
Pfizer Inc. (PFE)
6.78%
UnitedHealth Group Incorporated (UNH)
6.59%
Merck & Co. Inc. (MRK)
5.86%
Abbott Laboratories (ABT)
4.02%
AbbVie Inc. (ABBV)
3.55%
Medtronic plc (MDT)
3.5%
Amgen Inc. (AMGN)
3.42%
Thermo Fisher Scientific Inc. (TMO)
3.24%
Eli Lilly and Company (LLY)
3.08%
Gilead Sciences Inc. (GILD)
2.49%
Danaher Corporation (DHR)
2.47%
Bristol-Myers Squibb Company (BMY)
2.3%
CVS Health Corporation (CVS)
2.12%
Celgene Corporation (CELG)
2.04%
Anthem Inc. (ANTM)
1.91%
Becton Dickinson and Company (BDX)
1.9%
Intuitive Surgical Inc. (ISRG)
1.87%
Cigna Corporation (CI)
1.75%
Stryker Corporation (SYK)
1.73%
Boston Scientific Corporation (BSX)
1.51%
Zoetis Inc. Class A (ZTS)
1.47%
Illumina Inc. (ILMN)
1.45%
Biogen Inc. (BIIB)
1.38%
Allergan plc (AGN)
1.36%
Vertex Pharmaceuticals Incorporated (VRTX)
1.33%
Edwards Lifesciences Corporation (EW)
1.14%
Baxter International Inc. (BAX)
1.1%
Humana Inc. (HUM)
1.01%
HCA Healthcare Inc (HCA)
0.95%
Alexion Pharmaceuticals Inc. (ALXN)
0.87%
Regeneron Pharmaceuticals Inc. (REGN)
0.81%
Zimmer Biomet Holdings Inc. (ZBH)
0.76%
Agilent Technologies Inc. (A)
0.75%
McKesson Corporation (MCK)
0.68%
IQVIA Holdings Inc (IQV)
0.65%
Align Technology Inc. (ALGN)
0.63%
Cerner Corporation (CERN)
0.63%
Centene Corporation (CNC)
0.62%
IDEXX Laboratories Inc. (IDXX)
0.58%
Mettler-Toledo International Inc. (MTD)
0.56%
Waters Corporation (WAT)
0.53%
Laboratory Corporation of America Holdings (LH)
0.44%
ResMed Inc. (RMD)
0.44%
Cooper Companies Inc. (COO)
0.43%
Mylan N.V. (MYL)
0.43%
Cardinal Health Inc. (CAH)
0.42%
Incyte Corporation (INCY)
0.41%
Teleflex Incorporated (TFX)
0.4%
WellCare Health Plans Inc. (WCG)
0.39%
Varian Medical Systems Inc. (VAR)
0.37%
Hologic Inc. (HOLX)
0.36%
Quest Diagnostics Incorporated (DGX)
0.36%
ABIOMED Inc. (ABMD)
0.36%
AmerisourceBergen Corporation (ABC)
0.35%
DENTSPLY SIRONA Inc. (XRAY)
0.34%
PerkinElmer Inc. (PKI)
0.32%
Universal Health Services Inc. Class B (UHS)
0.32%
Henry Schein Inc. (HSIC)
0.29%
STATE STREET INSTL US GOVERNME STIF USD (85749246)
0.23%
DaVita Inc. (DVA)
0.2%
Perrigo Co. Plc (PRGO)
0.19%
Nektar Therapeutics (NKTR)
0.17%
U.S. Dollar
0.01%
Health Care Select Sector SPDR Fund (XLV)
0%
XLV Technicals
Alpha
1.62
Beta
0.97
Leverage
Long
Standard Deviation
3.83
XLV Dividends
Dividend Date
2019-03-15
Latest Dividend
0.341
Annual Dividend
1.4
Annual Dividend Rate
1.4
Annual Dividend Yield
1.63
XLV Performance
YTD Return
-0.62%
1 Year Return
4.73%
3 Year Return
23.18%
5 Year Return
48.87%
10 Year Return
255.54%
XLV Related Articles
Healthcare, Biotech ETFs Plunge on Mounting Political Pressures
Healthcare stocks and sector-related exchange traded funds took a heavy blow Wednesday, trailing the broader market by a historic margin…
Healthcare ETFs Lag the Broader Market Amidst Regulation Scare
Once an outperformer last, providing investors a defensive play in 2018, the healthcare sector and related ETFs are now among…
Tom Lydon on CNBC: Can Health Care Cure Itself?
Uncertainty and skepticism are a cause of sickness in the tried-and-true health care sector, which has been the worst performer…
Will Tighter Government Regulation Test Health Care ETFs?
Whether the markets are roaring or experiencing doldrums, health care exchange-traded funds (ETFs) have been a paragon of reliability, but…
Healthcare ETFs Deteriorate on Congress’ Threats to Drug Prices
Healthcare sector-specific ETFs took a blow Friday after the U.S. Congress threatened legislative action on rising costs of prescription drugs…